THE ORGANIZATION AWARDED GRANT FUNDING TO SUPPORT THE NC VVIRAL PROJECT AND TEAM IN THEIR EFFORTS TO IMPROVE THE EFFICIENCY, PRODUCTIVITY, AND COST OF MANUFACTURING VIRAL VECTORS FOR GENE THERAPIES. Due to a delay in reporting requirements, the fiscal year 2024 grant was awarded and paid in December 2024.